Medical Technology - EMEA

  • EMEA
  • The Medical Technology market market in the Europe, Middle East, and Africa (in Europe, the Middle East, and Africa) region is anticipated to achieve a revenue of US$204.00bn by the year 2024.
  • Among the various markets within this market, the largest one is Medical Devices, which is expected to reach a market volume of US$176.60bn in the same year.
  • This market is projected to exhibit a compound annual growth rate (CAGR 2024-2029) of 4.81%, leading to a market volume of US$258.00bn by 2029.
  • In terms of global comparison, the United States is predicted to generate the highest revenue, amounting to US$210.00bn in 2024.
  • In Germany, the Medical Technology market is experiencing a growing demand for innovative devices and solutions to support the country's aging population.

Key regions: United States, Germany, China, Japan, France

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Medical Technology market in EMEA is experiencing significant growth and development due to various factors. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors all contribute to the current state of the industry. Customer preferences in the Medical Technology market in EMEA are driving the demand for innovative and advanced medical devices. Customers are increasingly seeking products that offer improved patient outcomes, enhanced efficiency, and cost-effectiveness. This has led to a rise in the adoption of technologies such as telemedicine, remote patient monitoring, and wearable devices. Additionally, there is a growing focus on personalized medicine, with customers demanding tailored solutions that address their specific healthcare needs. Trends in the market further contribute to the development of the Medical Technology industry in EMEA. One key trend is the increasing digitization of healthcare systems. This includes the adoption of electronic health records, data analytics, and artificial intelligence, which enable healthcare providers to deliver more efficient and personalized care. Another trend is the convergence of medical technology with other industries, such as information technology and telecommunications, leading to the development of innovative solutions and partnerships. Local special circumstances also play a role in shaping the Medical Technology market in EMEA. Each country in the region has its own unique healthcare system, regulations, and reimbursement policies. These factors can impact the adoption and availability of medical technologies in different markets. Additionally, cultural and demographic factors can influence customer preferences and demand for specific types of medical devices. Underlying macroeconomic factors also contribute to the development of the Medical Technology market in EMEA. Economic growth, increasing healthcare expenditure, and government initiatives to improve healthcare infrastructure and access to medical services all drive the demand for medical technologies. Additionally, an aging population and the prevalence of chronic diseases in the region create a need for advanced medical devices and technologies that can effectively manage these conditions. In conclusion, the Medical Technology market in EMEA is experiencing growth and development driven by customer preferences, market trends, local special circumstances, and underlying macroeconomic factors. The demand for innovative and advanced medical devices, the digitization of healthcare systems, unique market conditions in each country, and favorable macroeconomic conditions all contribute to the current state of the industry.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)